p53 tumor suppressor gene protein expression in premalignant and malignant skin lesions of kidney transplant recipients

Journal of the American Academy of Dermatology

Volumn 36, Issue 6 I, 1997, Pages 924-931

  Gibson, G E ^a   O'Grady, A ^a   Kay, E W ^a   Leader, M ^a   Murphy, G M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETRETINATE; PROTEIN P53;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; CLINICAL ARTICLE; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY TRANSPLANTATION; MALE; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CANCER; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; VERRUCA VULGARIS;

EID: 0030905583     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(97)80274-5     Document Type: Article

References (37)

1. Lane D.P. Crawford L.V. T antigen is bound to a host protein in SV 40-transformed cells Nature 278 1979 261 263
2. Hollstein M. Sidransky D. Vogelstein B. Harris C.C. p53 mutations in human cancers Science 253 1991 49 53
3. Hainaut P. The tumour suppressor protein p53: a receptor to genotoxic stress that controls cell growth and survival Curr Opin Oncol 7 1995 76 82
4. Brash D.E. Rudolph J.A. Simon J.A. A role for sunlight in skin cancer: UV-induced p53 mutations in SCC Proc Natl Acad Sci USA 88 1991 10124 10128
5. Bouwes Bavinck J.N. Tieben L.M. Van Der Woude F.J. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study J Clin Oncol 13 1995 1933 1938
6. Shuttleworth D. Marks R. Griffin P.J.A. Salaman J.R. Treatment of cutaneous neoplasia with etretinate in renal transplant recipients Q J Med 257 1988 717 724
7. Kraemer K.H. DiGiovanni J.J. Moshell A.N. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin N Engl J Med 318 1988 1633 1637
8. Verret J.L. Schnitzler L. Avenel A. Smulevici A. Etretinate and skin cancer prevention: a 6.5 year follow-up study Saurat J.-H. Retinoids: new trends in research and therapy 1985 Karger Basel 355 359
9. Peck G.L. Therapy and prevention of skin cancer Sanrat J.-H. Retinoids: new trends in research and therapy 1985 Karger Basel 345 354
10. Peck G.L. DiGiovanni J.J. Samoff D.S. Treatment and prevention of basal cell carcinoma with oral isotretinoin J Am Acad Dermatol 19 1988 176 185
11. Shuttleworth D Marks R Griffin P.J.A. Salaman J.R. Treatment of cutaneous neoplasia with etretinate in renal transplant recipients Q J Med 257 1988 717 724
12. Kelly J.W. Sabto J. Gurr F.W. Retinoids to prevent skin cancer in organ transplant recipients Lancet 2 1991 1407
13. Vandeghinste N. De Bersaques J. Geerts M.L. Kint A. Acitretin as cancer chemoprophylaxis in a renal transplant recipient Dermatology 185 1992 307 308
14. Bouwes Bavinck J.N. Tieben L.M. Van Der Woude F.K. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study J Clin Onco1 13 1995 1933 1938
15. McKee P.H. Hobbs C. Hall P.A. Antigen retrieval by microwave irradiation lowers immunohistological detection thresholds Histopathology 23 1993 377 379
16. Garcia R.L. Coltrera M.D. Gown A.M. Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed embedded tissues: comparison with flow cytometric analysis Am J Pathol 134 1989 733 739
17. Martinez J. Georgoff I. Martinez J. Cellular localization and cell regulation by a temperature-sensitive p53 protein Genes Dev 5 1991 151 159
18. Levine A.J. Momand J. Finlay C.A. The p53 tumor suppressor gene Nature 351 1991 453 456
19. Lane D.P. Benchimol S. p53: oncogene or anti-oncogene Genes Dev 4 1990 1 8
20. Gusterson B.A Anbazhagan R. Warren W. Expression of p53 in premalignant and malignant squamous epithelium Oncogene 6 1991 1785 1789
21. Bennett W.P. Hollstein M.C. He A. Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer Oncogene 6 1991 1779 1784
22. Thompson A.M. Steel C.M. Chetty U. p53 gene mRNA expression and chromosome 17p allele loss in breast cancer Br J Cancer 61 1990 74 78
23. Campbell C. Quinn A.G. Angus B. Rees J.L. The relation between p53 mutation and p53 immunostaining in nonmelanoma skin cancer Br J Dermatol 129 1993 235 241
24. Baas I.O. Mulder J.W.R. Offerhaus J.A. Vogelstein B. Hamilton S.R. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms J Pathol 172 1994 5 12
25. Wynford-Thomas D. p53 in tumour pathology: Can we trust immunohistochemistry? J Pathol 166 1992 329 330
26. Stephenson T.J. Royds J Silcocks P.B. Mutant p53 oncogene expression in keratoacanthoma and squamous cell carcinoma Br J Dermatol 127 1992 566 570
27. McGregor J.M. Yu C.C.-W. Dublin E.A. Aberrant expression of p53 tumor-suppressor protein in non-melanoma skin cancer Br J Dermatol 127 1992 463 469
28. Shea C.R. McNutt N.S. Volkenandt M. Overexpression of p53 protein in basal cell carcinomas of human skin Am J Pathol 141 1992 25 29
29. Ziegler A. Leffell D.J. Kunala S. Mutation hotspots due to sunlight in the p53 gene of non-melanoma skin cancers Proc Natl Acad Sci USA 90 1993 4216 4220
30. Hall P.A. Lane D.P. p53 in tumour pathology: Can we trust immunohistochemistry?—Revisited! J Pathol 172 1994 1 4
31. Bennett MA, O'Grady A, Kay EW, Leader M, Murphy GM. P53 point mutations in squamous cell carcinomas from Irish renal transplant patients. From Book of Poster Abstracts, 54th Annual Meeting of the American Academy of Dermatology, P-234.
32. Burns P.A. Kemp C.J. Gannon J.V. Loss of heterozygosity and mutational alterations of the p53 gene in skin tumours of interspecific hybrid mice Oncogene 6 1991 2363 2369
33. Baker S.J. Preisinger A.C. Jessup J.M. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis Cancer Res 50 1990 7717 7722
34. Ro Y.S. Cooper P.N. Lee J.A. p53 protein expression in benign and malignant skin tumours Br J Dermatol 128 1993 237 241
35. Oram Y.O. Orengo I. Baer S.C. Ocal T. p53 protein expression in squamous cell carcinomas from sun-exposed and non-sun-exposed sites J Am Acad Dermatol 31 1994 417 722
36. Nagano T. Uedo M. Ichihashi M. Expression of p53 protein is an early event in ultraviolet light-induced cutaneous squamous cell carcinogenesis. Arch Dermatol 129 1993 1157 1161
37. Betz N.A. Pelling J.C. Resistance of adult keratinocytes to differentiation-induced increase in Ha-ras mRNA levels observed in newborn keratinocytes Mol Carcinog 6 1992 10 17